AIS CHANNEL - The ultimate surgical training experience!

5 Things you should know about Cytoreductive Surgery and HIPEC in peritoneal carcinomatosis from peritoneal [...]

This SOC describes the initial diagnostic and therapeutic approach for peritoneal malignancy due to Diffuse Malignant Peritoneal Mesothelioma.

Learning Curve in Robotic Colorectal Surgery

The learning curve in robotic colorectal surgery has not been established. We review the main steps to take in robotic [...]

Rectal Cancer – Watch & Wait Complete Clinical Response

Since its first description by Professor Angelita Habr-Gama’s team, the Watch & Wait strategy for rectal cancer has been gaining [...]

Evolution and Impact of the AIS COVID-19 Resources Center

The creation of a resource center by Advances in Surgery in collaboration with Johnson & Johnson Institute has had an [...]

Current Role of Stem Cells in Complex Anorectal Disease

Mesenchymal stem cells are the most recent therapy used for the treatment of complex anal fistula and it has been [...]

Treatment of Esophageal Perforations. Why, when and how?

Esophageal perforation is most commonly iatrogenic. Independently of the etiology, esophageal perforation is a surgical emergency associated with significant morbidity [...]

Acute Surgical Emergencies in IBD – Current Practices

Great advances have been made in the medical treatment for IBD, but little has changed regarding surgical technique for IBD [...]

Surgical Management of Hemorrhoids

Hemorrhoids is one of the most common anorectal diseases encountered daily by surgeons and general practitioners. Based on the degree [...]

5 Things You Should Know about Therapies for early Rectal Cancer

Local excision alone is considered oncological safe for low risk T1 rectal cancer: well or moderately differentiated without lymphatic/vascular invasion [...]

Complications after Thyroid Surgery

The aim of this open classroom is to review the most common complications after thyroid surgery. The three most frequent [...]

Cytoreductive Surgery and HIPEC in Peritoneal Carcinomatosis from Pseudomyxoma Peritonei: A Review of the evidence-based [...]

Pseudomyxoma peritonei is the intraperitoneal dissemination of free mucus produced by adenomucinous tumoral cells. Currently, the CRS-HIPEC is the standard [...]